4 Results for: created: (01/2018 to 01/2018)

People

  1. Pietanza
    Pietanza
  2. Kris
    Kris
  3. Rudin
    Rudin
  4. Travis
    Travis
  5. Bensman
    Bensman
  6. Dunphy
    Dunphy
  7. Fleisher
    Fleisher
  8. Foster
    Foster
  9. Gelblum
    Gelblum
  10. Hurtado
    Hurtado

Groups

  1. Department of Medicine (3)
  2. Solid Tumor Oncology Division (3)
  3. Thoracic Oncology (3)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  5. Department of Pathology and Laboratory Medicine (2)
  6. GSK Faculty (2)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (1)
  8. Center for Molecular Imaging and Biotechnology (1)
  9. Molecular Imaging and Therapy Service (1)
  10. Radiation Oncology, Department of (1)
  1. "Maria Pietanza"
Formats
  1. Meeting Abstract (3)
  2. Book Section (1)
Groups
  1. Department of Medicine (3)
  2. Solid Tumor Oncology Division (3)
  3. Thoracic Oncology (3)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
  5. Department of Pathology and Laboratory Medicine (2)
  6. GSK Faculty (2)

More Groups

People
  1. Maria Pietanza (4)
  2. Charles Rudin (2)
  3. Mark Kris (2)
  4. William Travis (2)
  5. Abraham Wu (1)
  6. Amanda Foster (1)

More People

Years
  1. 2017 (2)
  2. 2014 (1)
  3. 2011 (1)
Publications
  1. Journal of Thoracic Oncology (2)
  2. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 9th ed (1)
  3. Journal of Nuclear Medicine (1)
Publishers
  1. Elsevier Inc. (2)
  2. Society of Nuclear Medicine (1)
  3. Wolters Kluwer Health | Lippincott Williams & Wilkins (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Improved small cell lung cancer (SCLC) response rates with veliparib and temozolomide: Results from a phase II trial
    Meeting Abstract

    Byers, L. A.; Krug, L.; Waqar, S.; Dowlati, A.; Hann, C.; Chiappori, A.; Owonikoko, T.; Woo, K.; Bensman, Y.; Hurtado, B.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Single-agent rovalpituzumab tesirine, a delta-like protein 3 (DLL3)-targeted antibody-drug conjugate (ADC), in small-cell lung cancer (SCLC)
    Meeting Abstract

    Spigel, D.; Pietanza, M. C.; Bauer, T.; Ready, N.; Morgensztern, D.; Glisson, B. S.; Byers, L. A.; Johnson, M.; Burris, H.; Robert, F.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Prognostic value of SUV and non-SUV PET metrics in pre-chemoradiotherapy patients in limited-stage small cell lung cancer
    Meeting Abstract

    Ong, L.; Wu, A.; Foster, A.; Perez, C.; Pietanza, M.; Rosenzweig, K.; Gelblum, D.; Rimner, A.; Dunphy, M.
    Journal of Nuclear Medicine (2014)

    Fulltext@MSK | Save
  • Small cell and neuroendocrine tumors of the lung
    Book Section

    Krug, L. M.; Pietanza, M. C.; Kris, M. G.; Rosenzweig, K.; Travis, W. D.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 9th ed (2011)

    Fulltext@MSK | Save